出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2017/01/29 23:28:33」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells.
  • Nakano T1, Inoue R2, Kimura T3, Suzumura H4, Tanino T5, Yamazaki Y6, Yoshikawa K7, Tatemichi M8.
  • Advances in therapy.Adv Ther.2016 Aug;33(8):1452-9. doi: 10.1007/s12325-016-0373-y. Epub 2016 Jul 6.
  • INTRODUCTION: This clinical study aimed to investigate the effect of brinzolamide, a topical carbonic anhydrase inhibitor, on corneal endothelial cells (CECs) in patients with glaucoma using a follow-up clinical study design.METHODS: Patients with primary open-angle glaucoma or ocular hypertension w
  • PMID 27384190
  • Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics.
  • Quaranta L1, Biagioli E2, Galli F3, Poli D3, Rulli E3, Riva I1, Hollander L3, Katsanos A4, Longo A5, Uva MG5, Torri V3, Weinreb RN6.
  • Advances in therapy.Adv Ther.2016 Aug;33(8):1305-15. doi: 10.1007/s12325-016-0358-x. Epub 2016 Jun 16.
  • INTRODUCTION: To investigate the efficacy of a treatment strategy with latanoprost and dorzolamide in primary pediatric glaucoma patients partially responsive to surgery.METHODS: Single arm, prospective, interventional multicenter study. Primary pediatric glaucoma patients younger than 13 years aft
  • PMID 27312975
  • Determination of phosphate concentration in glaucoma eye drops commercially available in Spain.
  • Martínez-Soroa I1, de Frutos-Lezaun M2, Ostra Beldarrain M3, Egía Zurutuza A3, Irastorza Larburu MB4, Bachiller Cacho MP4.
  • Archivos de la Sociedad Espanola de Oftalmologia.Arch Soc Esp Oftalmol.2016 Aug;91(8):363-371. doi: 10.1016/j.oftal.2016.02.010. Epub 2016 Mar 24.
  • OBJECTIVES: To identify and analyze the phosphate concentration in glaucoma eye drops available in Spain.MATERIAL AND METHODS: Glaucoma medications containing phosphates were identified according to the 2013 Vademecum and the website of the Spanish Agency for Medicines and Medical Devices. Phosphate
  • PMID 27017538


  • 安息香酸ナトリウム含有ラタノプロスト点眼液への切替えによる薬剤性角膜上皮障害の改善効果
  • 南 泰明,星 最智,近藤 衣里 [他]
  • あたらしい眼科 29(10), 1401-1404, 2012-10
  • NAID 40019470804
  • 緑内障治療薬配合剤の単回点眼による健常者視神経乳頭血流に及ぼす影響 (第22回日本緑内障学会)
  • 笠原 正行,庄司 信行,森田 哲也 [他]
  • あたらしい眼科 29(8), 1136-1140, 2012-08
  • NAID 40019415669
  • CLINICAL INVESTIGATION : Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy
  • Kashiwagi Kenji
  • Japanese journal of ophthalmology : the official English-language journal of the Japanese Ophthalmological Society 56(4), 339-345, 2012-07
  • NAID 40019342305


Latanoprost comes as eye drops. Usually, one drop is applied to the affected eye(s) once a day in the evening. If latanoprost is used with other topical eye medications, allow at least 5 minutes between each medication. Follow the ...
Before using latanoprost drops: Some medical conditions may interact with latanoprost drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you: if you are pregnant ...


medication latanoprost what is latanoprost XALATAN LATANOPROST 0.005% EYE DROPS 2.5ML Latanoprost Ophthalmic Solution 0.005 2.5 Latanoprost Drops - patient information 200latanoprost ophthalmic : Uses, Side




  • プロスタグランディンPGF2α誘導体。ぶどう膜強膜流出経路から房水流出を促進する。